Letter to Editor
BibTex RIS Cite

İnme Ayırıcı Tanısında Kullanılan Belirteçleri Keşfetmek: Devam Eden Klinik Denemelerden İçgörüler

Year 2024, Volume: 8 Issue: 3, 264 - 265, 17.12.2024
https://doi.org/10.46332/aemj.1409453

Abstract

Devam eden klinik çalışmaların içgörülerine dayanarak, inme ayırıcı tanısında potansiyel belirteçlerin keşfinde önemli bir adım atılmasını beklenmektedir. İnme ayırıcı tanısında klinik pratiği büyük ölçüde etkileyebileceği göz önüne alındığında, bu çalışmaların potansiyel tanısal belirteçlerin tanımlanması ve doğrulanması konusundaki önemi yüksektir. Belirteç paneli geliştirmek, iskemik ve hemorajik inmeleri ayırt etmekte ve daha hızlı, doğru bir teşhis koymakta yardımcı olabilir. Ancak, heterojen inme popülasyonları ve farklı hastalık evreleri göz önüne alındığında, daha büyük örneklemler ve standardize edilmiş değerlendirme yöntemleri gerekliliğini korumaktadır. Gelecekteki çalışmalar, bu alandaki bilgi boşluklarını doldurabilir ve inme tanısında belirteçlerin klinik uygulamadaki rolünü netleştirebilir.

References

  • 1. Yetiş A, Çelikbilek A, Kaya Tekeşin A, Yağiz O. Homocysteine Levels in Patients with Hemorrhagic Stroke. Ahi Evran Med J. 2023;7(1):101-105.
  • 2. Yew KS, Cheng E. Acute stroke diagnosis. Am Fam Physician. 2009;80(1):33-40.
  • 3. Simpkins AN, Janowski M, Oz HS, et al. Biomarker Application for Precision Medicine in Stroke. Transl Stroke Res. 2020;11(4):615-627.
  • 4. Özdemir S, Cimilli T, Onur ÖE. Relationship between the National Institutes Health Stroke Scale Score and Bispectral Index in Patients with Acute Ischemic Stroke. J Exp Clin Med. 2021;38(4):440-444.
  • 5. Raha O, Hall C, Malik A, et al. Advances in mechanical thrombectomy for acute ischaemic stroke. BMJ Med. 2023;2(1):e000407.
  • 6. Aslan T, Eroğlu SE, İslam MM, et al. Diagnostic value of ABCD2 and ABCD3-I risk scoring systems in determining one-month risk of stroke in patients with transient ischemic attack: An observational study. J. Acute Dis. 2023;12(5):192-197.
  • 7. Toyoda K, Yoshimura S, Nakai M, et al; Japan Stroke Data Bank Investigators. Twenty-Year Change in Severity and Outcome of Ischemic and Hemorrhagic Strokes. JAMA Neurol. 2022;79(1):61-69.
  • 8. Minhas JS, Moullaali TJ, Rinkel GJE, Anderson CS. Blood Pressure Management After Intracerebral and Subarachnoid Hemorrhage: The Knowns and Known Unknowns. Stroke. 2022;53(4):1065-1073.
  • 9. Jin J, Duan J, Du L, Xing W, Peng X, Zhao Q. Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies. Front Immunol. 2022;13:1027756.
  • 10. Jordan LC, Hillis AE. Challenges in the diagnosis and treatment of pediatric stroke. Nat Rev Neurol. 2011;7(4):199-208.

Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials

Year 2024, Volume: 8 Issue: 3, 264 - 265, 17.12.2024
https://doi.org/10.46332/aemj.1409453

Abstract

Based on insights from ongoing clinical studies, a significant step forward in the discovery of potential markers in the differential diagnosis of stroke is expected. Considering that the differential diagnosis of stroke can greatly influence clinical practice, the importance of these studies in identifying and validating potential diagnostic markers is high. Developing a marker panel may help distinguish ischemic and hemorrhagic strokes and provide a faster, more accurate diagnosis. However, considering heterogeneous stroke populations and different disease stages, larger samples and standardized assessment methods remain necessary. Future studies may fill knowledge gaps in this field and clarify the role of markers in stroke diagnosis in clinical practice.

References

  • 1. Yetiş A, Çelikbilek A, Kaya Tekeşin A, Yağiz O. Homocysteine Levels in Patients with Hemorrhagic Stroke. Ahi Evran Med J. 2023;7(1):101-105.
  • 2. Yew KS, Cheng E. Acute stroke diagnosis. Am Fam Physician. 2009;80(1):33-40.
  • 3. Simpkins AN, Janowski M, Oz HS, et al. Biomarker Application for Precision Medicine in Stroke. Transl Stroke Res. 2020;11(4):615-627.
  • 4. Özdemir S, Cimilli T, Onur ÖE. Relationship between the National Institutes Health Stroke Scale Score and Bispectral Index in Patients with Acute Ischemic Stroke. J Exp Clin Med. 2021;38(4):440-444.
  • 5. Raha O, Hall C, Malik A, et al. Advances in mechanical thrombectomy for acute ischaemic stroke. BMJ Med. 2023;2(1):e000407.
  • 6. Aslan T, Eroğlu SE, İslam MM, et al. Diagnostic value of ABCD2 and ABCD3-I risk scoring systems in determining one-month risk of stroke in patients with transient ischemic attack: An observational study. J. Acute Dis. 2023;12(5):192-197.
  • 7. Toyoda K, Yoshimura S, Nakai M, et al; Japan Stroke Data Bank Investigators. Twenty-Year Change in Severity and Outcome of Ischemic and Hemorrhagic Strokes. JAMA Neurol. 2022;79(1):61-69.
  • 8. Minhas JS, Moullaali TJ, Rinkel GJE, Anderson CS. Blood Pressure Management After Intracerebral and Subarachnoid Hemorrhage: The Knowns and Known Unknowns. Stroke. 2022;53(4):1065-1073.
  • 9. Jin J, Duan J, Du L, Xing W, Peng X, Zhao Q. Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies. Front Immunol. 2022;13:1027756.
  • 10. Jordan LC, Hillis AE. Challenges in the diagnosis and treatment of pediatric stroke. Nat Rev Neurol. 2011;7(4):199-208.
There are 10 citations in total.

Details

Primary Language English
Subjects Emergency Medicine
Journal Section Letter to the Editor
Authors

Serdar Özdemir 0000-0002-6186-6110

Hatice Şeyma Akça 0000-0003-2823-9577

Early Pub Date December 11, 2024
Publication Date December 17, 2024
Submission Date December 26, 2023
Acceptance Date June 11, 2024
Published in Issue Year 2024 Volume: 8 Issue: 3

Cite

APA Özdemir, S., & Akça, H. Ş. (2024). Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials. Ahi Evran Medical Journal, 8(3), 264-265. https://doi.org/10.46332/aemj.1409453
AMA Özdemir S, Akça HŞ. Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials. Ahi Evran Med J. December 2024;8(3):264-265. doi:10.46332/aemj.1409453
Chicago Özdemir, Serdar, and Hatice Şeyma Akça. “Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials”. Ahi Evran Medical Journal 8, no. 3 (December 2024): 264-65. https://doi.org/10.46332/aemj.1409453.
EndNote Özdemir S, Akça HŞ (December 1, 2024) Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials. Ahi Evran Medical Journal 8 3 264–265.
IEEE S. Özdemir and H. Ş. Akça, “Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials”, Ahi Evran Med J, vol. 8, no. 3, pp. 264–265, 2024, doi: 10.46332/aemj.1409453.
ISNAD Özdemir, Serdar - Akça, Hatice Şeyma. “Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials”. Ahi Evran Medical Journal 8/3 (December 2024), 264-265. https://doi.org/10.46332/aemj.1409453.
JAMA Özdemir S, Akça HŞ. Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials. Ahi Evran Med J. 2024;8:264–265.
MLA Özdemir, Serdar and Hatice Şeyma Akça. “Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials”. Ahi Evran Medical Journal, vol. 8, no. 3, 2024, pp. 264-5, doi:10.46332/aemj.1409453.
Vancouver Özdemir S, Akça HŞ. Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials. Ahi Evran Med J. 2024;8(3):264-5.

Ahi Evran Medical Journal  is indexed in ULAKBIM TR Index, Turkish Medline, DOAJ, Index Copernicus, EBSCO and Turkey Citation Index. Ahi Evran Medical Journal is periodical scientific publication. Can not be cited without reference. Responsibility of the articles belong to the authors.

    Creative Commons Lisansı

This journal is licensed under the Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı.